Pharmaceutical T4 Synthetic Compound Overview
T4 Dragon Pharma is a synthetic levothyroxine sodium preparation developed for advanced metabolic research applications. This pharmaceutical-grade compound represents the synthetic form of thyroxine (3,5,3′,5′-tetraiodothyronine), the primary hormone produced by the thyroid gland. Research laboratories utilise this standardised preparation to examine thyroid hormone receptor mechanisms, metabolic pathway modulation, and cellular energy regulation processes in controlled experimental settings.
The compound serves as an essential research tool for investigating thyroidal axis function and metabolic homeostasis. Scientists at Stroid UK Shop and affiliated research institutions examine how synthetic levothyroxine influences cellular metabolic processes, mitochondrial function, and energy expenditure pathways in various experimental models.
Laboratory Research Applications
Research teams investigate T4’s role in metabolic regulation through detailed analysis of thyroid receptor binding affinity and downstream signalling cascades. This synthetic preparation enables controlled studies of thyroidal hormone kinetics, tissue-specific receptor activation, and metabolic rate modulation mechanisms. Laboratory protocols examine the compound’s interaction with deiodinase enzymes responsible for T4 to T3 conversion in peripheral tissues.
Metabolic research applications include analysis of thermogenesis pathways, lipid metabolism regulation, and protein synthesis modulation. Scientists studying metabolic modulators often compare T4’s mechanisms with other thyroidal compounds to understand differential receptor activation patterns. Comparative studies with selective androgen receptor modulators examine potential synergistic metabolic effects, while peptide research investigates interactions between thyroidal and growth factor signalling pathways.
Technical Specifications
| Parameter | Specification |
|---|---|
| Chemical Name | Levothyroxine Sodium |
| IUPAC Name | Sodium (2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoate |
| CAS Number | 25416-65-3 |
| Molecular Formula | C₁₅H₁₀I₄NNaO₄ |
| Molecular Weight | 798.85 g/mol |
| Storage Conditions | Room temperature, dry environment, protected from light |
| Stability | Stable under recommended storage conditions |
| Manufacturer | Dragon Pharma |
Research Compliance Notice
T4 Dragon Pharma is manufactured exclusively for in-vitro laboratory research purposes and analytical testing protocols. This synthetic levothyroxine sodium preparation is not intended for human consumption, therapeutic applications, or any use outside controlled research environments. Research institutions must maintain appropriate laboratory protocols and safety procedures when handling this compound. All experimental work should be conducted by qualified laboratory personnel following institutional research guidelines and applicable regulatory frameworks.
